SEC-Show

BALCHEM CORP filed this DEF 14A on April 25, 2025

Back to Results Entire Filing Printer Friendly Outline

BALCHEM CORP - DEF 14A - 20250425 - OPTIONS

Executive Compensation

2024 Grants of Plan-Based Awards


Name	Grant Date	Grant Type	Estimated Future Payouts Under Non-Equity Incentive Plan Awards(1)			Estimated Future Payouts Under Equity Incentive Plan Awards(2)			All Other Stock Awards: Number of Shares of Stock (#)	All Other: Number of Securities Underlying Stock Options (#)	Exercise Price of Stock Option(3) ($/Share)	Grant Date Fair Value of Stock and Option Awards(4) ($)
Name	Grant Date	Grant Type	Threshold	Target	Maximum	Threshold (#)	Target (#)	Maximum (#)	All Other Stock Awards: Number of Shares of Stock (#)		Exercise Price of Stock Option(3) ($/Share)	Grant Date Fair Value of Stock and Option Awards(4) ($)
Ted Harris		ICP	$0	$1,270,500	$2,541,000
	02/08/2024	Performance Shares				5,885	11,770	23,540
	02/08/2024	Time-Based Restricted Shares							6,650
	02/08/2024	Stock Options								21,500	$143.43
												$3,819,530
C. Martin Bengtsson		ICP	$0	$429,112	$858,224
	02/08/2024	Performance Shares				1,860	3,720	7,440
	02/08/2024	Time-Based Restricted Shares							2,100
	02/08/2024	Stock Options								6,800	$143,43
												$1,207,225
Frederic Boned		ICP	$0	$310,875	$621,750
	02/08/2024	Performance Shares				1,220	2,440	4,880
	02/08/2024	Time-Based Restricted Shares							1,380
	02/08/2024	Stock Options								4,500	$143.43
												$793,866
Hatsuki Miyata		ICP	$0	$282,682	$565,363
	02/08/2024	Performance Shares				1,025	2,050	4,100
	02/08/2024	Time-Based Restricted Share Awards							1,160
	02/08/2024	Stock Options								3,800	$143.43
												$667,893
Martin Reid		ICP	$0	$280,847	$561,694
	02/08/2024	Performance Shares				930	1,860	3,720
	02/08/2024	Time-Based Restricted Shares							1,050
	02/08/2024	Stock Options								3,400	$143.43
												$603,612

(1)	The maximum amounts equal 200% of target. Additional information regarding the design of the ICP is included in the Compensation Discussion and Analysis.

(2)

The target number of shares shown in the table reflects the number of shares of our Common Stock earned if performance is achieved at target levels. All shares will be awarded net of applicable tax withholding. Dividend equivalents accrue during the performance cycle and will be paid out in shares, net of applicable tax withholding, based on the actual number of shares earned for the performance cycle, if any.

(3)	The exercise price equals the closing price of our Common Stock on the grant date except as otherwise indicated.

(4)	The amounts represent the grant date fair value of the awards as computed in accordance with FASB ASC Topic 718.